Market closed
ClearPoint Neuro/$CLPT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About ClearPoint Neuro
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
Ticker
$CLPT
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
107
Website
ClearPoint Neuro Metrics
BasicAdvanced
$460M
Market cap
-
P/E ratio
-$0.69
EPS
1.11
Beta
-
Dividend rate
Price and volume
Market cap
$460M
Beta
1.11
52-week high
$14.74
52-week low
$5.11
Average daily volume
252K
Financial strength
Current ratio
4.545
Quick ratio
3.456
Long term debt to equity
10.889
Total debt to equity
12.737
Management effectiveness
Return on assets (TTM)
-28.04%
Return on equity (TTM)
-68.36%
Valuation
Price to revenue (TTM)
14.409
Price to book
15.87
Price to tangible book (TTM)
16.21
Price to free cash flow (TTM)
-48.309
Growth
Revenue change (TTM)
36.34%
Earnings per share change (TTM)
-22.33%
3-year revenue growth (CAGR)
24.59%
3-year earnings per share growth (CAGR)
4.53%
What the Analysts think about ClearPoint Neuro
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for ClearPoint Neuro stock.
ClearPoint Neuro Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
ClearPoint Neuro Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
ClearPoint Neuro News
AllArticlesVideos
ClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
Accesswire·4 weeks ago
ClearPoint Neuro: Near-Term Volatility Is No Concern
Seeking Alpha·1 month ago
ClearPoint Neuro, Inc. (CLPT) Q3 2024 Earnings Call Transcript
Seeking Alpha·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for ClearPoint Neuro stock?
ClearPoint Neuro (CLPT) has a market cap of $460M as of December 12, 2024.
What is the P/E ratio for ClearPoint Neuro stock?
The price to earnings (P/E) ratio for ClearPoint Neuro (CLPT) stock is 0 as of December 12, 2024.
Does ClearPoint Neuro stock pay dividends?
No, ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders as of December 12, 2024.
When is the next ClearPoint Neuro dividend payment date?
ClearPoint Neuro (CLPT) stock does not pay dividends to its shareholders.
What is the beta indicator for ClearPoint Neuro?
ClearPoint Neuro (CLPT) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.